Evidence map›Paper›PMID 36158280›Full record

ReviewWorld journal of gastrointestinal surgery2022

From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s.

Francesco Auriemma, Sandro Sferrazza, Mario Bianchetti, Maria Flavia Savarese, Laura Lamonaca, Danilo Paduano, Nicole Piazza, Enrica Giuffrida, Lupe Sanchez Mete, Alessandra Tucci and 4 more

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Endoscopic Full Thickness Resection Device (FTRDDiagnostics (Basel, Switzerland) · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Francesco AuriemmaGastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza 21053, Italy.
Sandro SferrazzaGastroenterology and Endoscopy Unit, Santa Chiara Hospital, Trento 38014, Italy.
Mario BianchettiDigestive Endoscopy Unit, San Giuseppe Hospital - Multimedica, Milan 20123, Italy.
Maria Flavia SavareseDepartment of Gastroenterology and Gastrointestinal Endoscopy, General Hospital, Sanremo 18038, Italy.
Laura LamonacaGastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza 21053, Italy.
Danilo PaduanoGastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza 21053, Italy.
Nicole PiazzaGastroenterology Unit, IRCCS Policlinico San Donato, San Donato Milanese; Department of Biomedical Sciences for Health, University of Milan, Milan 20122, Italy.
Enrica GiuffridaGastroenterology and Hepatology Unit, A.O.U. Policlinico "G. Giaccone", Palermo 90127, Italy.
Lupe Sanchez MeteDepartment of Gastroenterology and Digestive Endoscopy, IRCCS Regina Elena National Cancer Institute, Rome 00144, Italy.
Alessandra TucciDepartment of Gastroenterology, Molinette Hospital, Città della salute e della Scienza di Torino, Turin 10126, Italy.
Sebastian Manuel MilluzzoDigestive Endoscopy Unit and Gastroenterology, Fondazione Poliambulanza, Brescia 25100, Italy.
Chiara IannelliDepartment of Health Sciences, Magna Graecia University, Catanzaro 88100, Italy.
Alessandro RepiciDigestive Endoscopy Unit and Gastroenterology, Humanitas Clinical and Research Center and Humanitas University, Rozzano 20089, Italy.
Benedetto MangiavillanoBiomedical Science, Hunimed, Pieve Emanuele 20090, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colonoscopy represents the most widespread and effective tool for the prevention and treatment of early stage preneoplastic and neoplastic lesions in the panorama of cancer screening. In the world there are different approaches to the topic of colorectal cancer prevention and screening: different starting ages (45-50 years); different initial screening tools such as fecal occult blood with immunohistochemical or immune-enzymatic tests; recto-sigmoidoscopy; and colonoscopy. The key aspects of this scenario are composed of a proper bowel preparation that ensures a valid diagnostic examination, experienced endoscopist in detection of preneoplastic and early neoplastic lesions and open-minded to upcoming artificial intelligence-aided examination, knowledge in the field of resection of these lesions (from cold-snaring, through endoscopic mucosal resection and endoscopic submucosal dissection, up to advanced tools), and management of complications.

Indexed as

Adverse eventsCold-endoscopic mucosal resectionColorectal lesionsColorectal tumorComplicationsEndoscopic mucosal resectionEndoscopic submucosal dissectionFTRD®Polypectomy

Identifiers

PMID36158280
PMCPMC9353749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.